About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting 12-09-2023 at 8:31 AM EST Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting 12-05-2023 at 7:31 AM EST Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update 11-09-2023 at 4:06 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 9, 2023 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q3 2023 Earnings Presentation 941.8 KB Morgan Stanley 21st Annual Global Healthcare Conference Sep 13, 2023 at 1:35 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 2, 2023 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2023 Earnings Presentation 1.2 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Dec 10, 2023 10:17 PM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
